FOLD

Amicus Therapeutics (FOLD)

Amicus Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:FOLD

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/12/04	08:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/12/03	06:43	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/11/15	11:00	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/11/15	01:37	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/11/14	23:31	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/11/08	07:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/11/08	07:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/11/07	07:03	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/11/07	06:02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/11/06	21:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/11/06	21:00	GlobeNewswire Inc.	Amicus Therapeutics Announces Third Quarter 2024 Financial Results and Corporate Updates	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/11/05	08:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/11/02	05:49	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/11/01	20:00	GlobeNewswire Inc.	Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/10/28	20:00	GlobeNewswire Inc.	Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/10/17	20:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/10/17	20:00	GlobeNewswire Inc.	Amicus Therapeutics Announces Settlement of Galafold® (migalastat) Patent Litigation with Teva	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/10/05	05:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/10/04	20:00	GlobeNewswire Inc.	Amicus Therapeutics Announces Participation at the World Muscle Society Annual Congress 2024	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/10/02	05:35	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/09/06	06:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/09/04	05:19	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/09/03	20:46	GlobeNewswire Inc.	UPDATE -- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/09/03	20:05	GlobeNewswire Inc.	Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/09/03	20:00	GlobeNewswire Inc.	Amicus Therapeutics Announces Participation at the SSIEM 2024 Annual Symposium	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/08/30	20:00	GlobeNewswire Inc.	Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/08/24	06:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/08/09	05:02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/08/08	20:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/08/08	20:00	GlobeNewswire Inc.	Amicus Therapeutics Announces Second Quarter 2024 Financial Results and Corporate Updates	NASDAQ:FOLD	Amicus Therapeutics Inc